Search for: "Apotex Inc."
Results 521 - 540
of 674
Sort by Relevance
|
Sort by Date
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
15 Feb 2009, 1:04 pm
Apotex, Inc., 2008 U.S. [read post]
4 Feb 2009, 7:00 am
Apotex, Inc., 2008 U.S. [read post]
22 Jan 2009, 2:06 am
Wyeth, Inc., 168 Cal. [read post]
13 Jan 2009, 8:41 am
800 Adept, Inc. v. [read post]
29 Dec 2008, 9:00 pm
Apotex, Inc., 521 F.3d 253 (3d Cir. 2008). [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
22 Dec 2008, 2:20 am
Apotex Inc. et al.1:08-cv-00948; filed December 17, 2008 in the District Court of DelawarePfizer Inc. et al. v. [read post]
20 Dec 2008, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oleg Teterin seeks ‘tens of thousands of dollars’ for rights to use ;-) emoticon, a registered Russian trade mark (Techdirt) (RelatIP) (Ars Technica) (The IP Factor) (Out-Law) (Class 46) New UK copyright consultation: consultation issues include access to works, incentivising investment and creativity, recognising… [read post]
19 Dec 2008, 3:04 pm
Apotex Inc. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of five patents owned by… [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
15 Dec 2008, 5:34 am
Apotex, Inc., No. 07-1438 (Fed. [read post]
12 Dec 2008, 8:42 am
See Amgen Inc. v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess… [read post]
7 Nov 2008, 8:35 am
The Supreme Court of Canada has issued its much anticipated patent decision Apotex Inc. v. [read post]
7 Nov 2008, 4:11 am
In a 7-0 judgment on 6 Nov 08, the Canadien Supreme Court rejected a request from Apotex Inc. to invalidate Sanofi's patent for an anti-coagulant drug (Plavix) used to combat cardiovascular degeneration.Coverage by Kirk Makin in the Globe and Mail did NOT get to the heart of this court battle involving patenting of racemates vs. patenting of enantiomers:Judge Rothstein said that in case of Sanofi's anti-coagulant drug - marketed under the name, Plavix - the company showed… [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC blog) Sustiva (Efavirenz) - Brazil: Compulsory licensed Efavirenz will be manufactured by public Brazilian laboratories by end of 2008 (IP tango) General A patent question of patents: Prof T Pogge's 'Health Impact Fund' alternative licensing system (Patent… [read post]
